This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Inventor Su Zeng
Introduction
Su Zeng is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of anti-tumor drug development. His work focuses on innovative compounds that have the potential to impact cancer treatment.
Latest Patents
Su Zeng holds a patent for a 6-dithio-substituted-2'-deoxyguanosine compound, along with its preparation method and applications. This invention provides a new approach to designing thioredoxin-1 (Trx-1) inhibitors using 2'-deoxyguanosine as a structural foundation. The compound demonstrates significant inhibitory activity against Trx-1, showcasing its potential as an anti-tumor agent. Research indicates that these compounds exhibit remarkable anti-tumor effects on various types of tumors, offering a promising avenue for the development of anticancer drugs.
Career Highlights
Su Zeng is affiliated with Zhejiang University, where he continues to advance his research in the field of medicinal chemistry. His innovative work has garnered attention for its potential applications in cancer therapy.
Collaborations
Su Zeng collaborates with esteemed colleagues, including Lushan Yu and Yang Zhang, who contribute to his research endeavors.
Conclusion
Su Zeng's contributions to the field of anti-tumor drug development highlight the importance of innovation in medical research. His patented compound represents a significant step forward in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile